As a government price-setting formula, the same arithmetic has produced the opposite result.
|Articles|February 17, 2003
Efficacy of anticoagulant can now be assessed at bedside
Clinicians now have a tool to rapidly assess the efficacy of enoxaparin (Lovenox, Aventis) at the point-of-care. PharmaNetics, Morrisville, NC, recently launched the ENOX test card, which is used to detect the anticoagulant effects of enoxaparin, which is approved for seven indications, including the prophylaxis of ischemic complications of unstable angina and non-Q wave myocardial infarction. Enoxaparin is approved for more clinical indications than any other low-molecular weight heparin. PharmaNetics plans to launch its product during the first quarter of 2003.
Advertisement
Advertisement
Related to this article
Orforglipron lowered A1C and body weight more than oral semaglutide 25 mg at 52 weeks, but the estimate comes from an indirect comparison.
Brian Smith, PharmD, explains how direct-to-consumer GLP-1 pathways broaden initial access but endanger long-term patient adherence.
Pharmacists face burnout and financial strain as PBMs take big cuts, prompting urgent calls for reform to protect patient care and community pharmacies.
What pharmacy technicians say would actually make them feel seen on World Pharmacy Technician Day, and the other 364 days of the year.
The analysis is not a head-to-head trial, and the weight loss gap reached statistical significance under 1 of 2 estimands.
A 1.6-million-birth analysis finds that adoption of a 2016 trial's antibiotic protocol climbed sharply in US hospitals, with a drop in infection rates.
New findings suggest semaglutide's benefits may extend well beyond diabetes and weight loss and into airway disease and mood disorders.
Advertisement
Advertisement